HSF1 and neurodegenerative disease: By contrast, a lack of Hsf1 activity has been suggested to contribute to neurodegenerative diseases with hallmark protein aggregates, and activation of Hsf1 has been proposed as a therapeutic avenue (Labbadia and Morimoto, 2015; Neef et al., 2011).